SS&C Unveils Next-Gen Hybrid Intelligent Automation Platform

SS&C Blue Prism Next Generation (Next Gen) represents a milestone in intelligent automation (IA), facilitating cloud adoption without compromising security and compliance WINDSOR, Conn., March 28, 2024 /PRNewswire/ — SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the first release of its new SS&C Blue Prism Next Generation intelligent automation platform. The platform is designed to deliver… Continue reading SS&C Unveils Next-Gen Hybrid Intelligent Automation Platform

SIA Names All Star Healthcare Solutions as a “Best Staffing Firm to Work For”

DEERFIELD BEACH, Fla., March 28, 2024 /PRNewswire/ — All Star Healthcare Solutions®, a full-service healthcare staffing company specializing in locum tenens and direct-hire opportunities for physicians, nurse practitioners, physician assistants, and certified registered nurse anesthetists, was named a 2024 Best Staffing Firm to Work For in the 201–500 employees’ category by Staffing Industry Analysts (SIA),… Continue reading SIA Names All Star Healthcare Solutions as a “Best Staffing Firm to Work For”

Boston Solar Commercial Division Completes Solar Installation for Twin Solar Systems at Framingham, MA Apartment Complex

WOBURN, Mass., March 28, 2024 /PRNewswire/ — SinglePoint Inc (CBOE: SING) (“SinglePoint” or “the Company”) subsidiary Boston Solar, a proud partner of the Boston Red Sox and a leading provider of solar energy solutions, proudly announces their transformative solar installation project at Pelham Apartments in Framingham, Massachusetts. This milestone emphasizes Boston Solar’s commitment to driving sustainable… Continue reading Boston Solar Commercial Division Completes Solar Installation for Twin Solar Systems at Framingham, MA Apartment Complex

Applied Intuition et Porsche annoncent des développements conjoints

MOUNTAIN VIEW, Californie, 28 mars 2024 /PRNewswire/ — Applied Intuition, fournisseur de logiciels automobiles basé dans la Silicon Valley, a annoncé aujourd’hui un partenariat stratégique avec le constructeur allemand de voitures de sport Porsche AG. L’objectif commun est le développement conjoint dans différents domaines de logiciels automobiles tout en maintenant la propriété des logiciels et en réduisant… Continue reading Applied Intuition et Porsche annoncent des développements conjoints

Jereh Group presenta el revolucionario equipo de tratamiento de residuos peligrosos GreenWell en la cippe de Beijing

BEIJING, 28 de marzo de 2024 /PRNewswire/ — Jereh causó sensación en la 24ª Exposición Internacional de Tecnología y Equipos Petroquímicos y Petroleros de China (cippe2024) en Beijing con su exhibición de innovaciones de vanguardia bajo el tema “Soluciones de explotación inteligente con tecnología baja en carbono”. Continue Reading Jereh Booth at cippe2024 Jereh, que… Continue reading Jereh Group presenta el revolucionario equipo de tratamiento de residuos peligrosos GreenWell en la cippe de Beijing

Tigermed Reports Full Year 2023 Results

HANGZHOU, China, March 28, 2024 /PRNewswire/ — Hangzhou Tigermed Consulting Co., Ltd. (“Tigermed” or the “company”) (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual results for the year ended December 31, 2023 (the “Reporting Period”). This press release is for… Continue reading Tigermed Reports Full Year 2023 Results

MESCIUS inc. Launches ActiveReports .NET v18

PITTSBURGH, March 28, 2024 /PRNewswire/ — MESCIUS inc., a global provider of award-winning enterprise software development tools, is pleased to announce the release of ActiveReports. NET v18. This major release includes exciting new features and improvements to the ActiveReports ecosystem. ActiveReports. NET v18 upgrades developers’ design toolkit for intuitive and dynamic reports. Continue Reading One… Continue reading MESCIUS inc. Launches ActiveReports .NET v18

Nested Therapeutics to Present Preclinical Data for NST-628, a Novel Pan-RAF/MEK Molecular Glue, in the New Drugs on the Horizon Series at 2024 AACR Annual Meeting

CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced that preclinical data from its lead program, NST-628, will be featured in an oral presentation in the “New Drugs on the Horizon” series at the American Association for Cancer Research (AACR) Annual Meeting… Continue reading Nested Therapeutics to Present Preclinical Data for NST-628, a Novel Pan-RAF/MEK Molecular Glue, in the New Drugs on the Horizon Series at 2024 AACR Annual Meeting

Ionis to hold olezarsen Phase 3 data webcast

Webcast scheduled for Monday, April 8 at 10:00 a.m. Eastern Time CARLSBAD, Calif., March 28, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Monday, April 8th at 10:00 a.m. Eastern Time to discuss the olezarsen Phase 3 Balance study results in patients with familial chylomicronemia syndrome… Continue reading Ionis to hold olezarsen Phase 3 data webcast

REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD

A single ABBV-RGX-314 gene therapy treatment has the potential to become a new standard-of-care option among anti-VEGF treatments by sustaining vision health long term and overcoming the clinical challenges of managing wet AMD due to the treatment burden of chronic anti-VEGF injections Patients who received therapeutic doses resulted in stable or improved vision and retinal… Continue reading REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD